Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics.
Felten R, Duret PM, Bauer E, Sedmak N, Djossou JH, Bensalem M, Ardizzone M, Geoffroy M, Fan A, Couderc M, Salmon JH, Messer L, Javier RM, Meyer A, Chatelus E, Sordet C, Pijnenburg L, Fort J, Rinagel M, Walther J, Fabre C, Arnaud L, Sibilia J, Meyer N, Berenbaum F, Chary-Valckenaere I, Soubrier M, Sellam J, Gottenberg JE. Felten R, et al. Among authors: meyer n, meyer a. Ann Rheum Dis. 2022 Jan;81(1):143-145. doi: 10.1136/annrheumdis-2021-220549. Epub 2021 Sep 23. Ann Rheum Dis. 2022. PMID: 34556483 No abstract available.
Seasonal effect on fatigue, pain and dryness in primary Sjögren's syndrome.
Duret PM, Meyer N, Saraux A, Devauchelle-Pensec V, Seror R, Le-Guern V, Larroche C, Perdriger A, Sibilia J, Guardiolle V, Mariette X, Gottenberg JE. Duret PM, et al. Among authors: meyer n. Arthritis Res Ther. 2020 Feb 24;22(1):39. doi: 10.1186/s13075-020-2118-1. Arthritis Res Ther. 2020. PMID: 32093783 Free PMC article.
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.
Felten R, Devauchelle-Pensec V, Seror R, Duffau P, Saadoun D, Hachulla E, Pierre Yves H, Salliot C, Perdriger A, Morel J, Mékinian A, Vittecoq O, Berthelot JM, Dernis E, Le Guern V, Dieudé P, Larroche C, Richez C, Martin T, Zarnitsky C, Blaison G, Kieffer P, Maurier F, Dellal A, Rist S, Andres E, Contis A, Chatelus E, Sordet C, Sibilia J, Arnold C, Tawk MY, Aberkane O, Holterbach L, Cacoub P, Saraux A, Mariette X, Meyer N, Gottenberg JE. Felten R, et al. Among authors: meyer n. Ann Rheum Dis. 2021 Mar;80(3):329-338. doi: 10.1136/annrheumdis-2020-218467. Epub 2020 Nov 18. Ann Rheum Dis. 2021. PMID: 33208345 Clinical Trial.
Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020.
Kaeuffer C, Le Hyaric C, Fabacher T, Mootien J, Dervieux B, Ruch Y, Hugerot A, Zhu YJ, Pointurier V, Clere-Jehl R, Greigert V, Kassegne L, Lefebvre N, Gallais F; Covid Alsace Study Group; Meyer N, Hansmann Y, Hinschberger O, Danion F; COVID Alsace Study Group. Kaeuffer C, et al. Among authors: meyer n. Euro Surveill. 2020 Dec;25(48):2000895. doi: 10.2807/1560-7917.ES.2020.25.48.2000895. Euro Surveill. 2020. PMID: 33272355 Free PMC article.
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.
Grzelak L, Velay A, Madec Y, Gallais F, Staropoli I, Schmidt-Mutter C, Wendling MJ, Meyer N, Planchais C, Rey D, Mouquet H, Reix N, Glady L, Hansmann Y, Bruel T, De Sèze J, Fontanet A, Gonzalez M, Schwartz O, Fafi-Kremer S. Grzelak L, et al. Among authors: meyer n. J Infect Dis. 2021 Sep 17;224(6):983-988. doi: 10.1093/infdis/jiab127. J Infect Dis. 2021. PMID: 33693749 Free PMC article.
1,294 results